doi: 10.1038/nm.2221.
Epub 2010 Sep 21.
Biomarkers in Alzheimer's disease drug development
Affiliations
- PMID: 21052077
- DOI: 10.1038/nm.2221
Item in Clipboard
Biomarkers in Alzheimer's disease drug development
Nat Med.
2010 Nov.
Abstract
Biomarkers may be of great value in Alzheimer's disease drug development to select the most optimal drug candidates for large and expensive phase 3 clinical trials. Biomarkers will also be important to provide evidence that a drug affects the underlying pathophysiology of the disease, which, together with a beneficial effect on the clinical course, will be essential for labeling the drug as having a disease-modifying effect.
Similar articles
-
Biomarkers in Alzheimer's disease drug development.Alzheimers Dement. 2011 May;7(3):e13-44. doi: 10.1016/j.jalz.2010.06.004. Epub 2011 May 6. Alzheimers Dement. 2011. PMID: 21550318 Review.
-
The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.Alzheimers Res Ther. 2017 Oct 26;9(1):85. doi: 10.1186/s13195-017-0312-4. Alzheimers Res Ther. 2017. PMID: 29070066 Free PMC article.
-
Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: Implication for future drug discovery and development for AD.Clin Transl Sci. 2009 Jun;2(3):242-7. doi: 10.1111/j.1752-8062.2009.00121.x. Clin Transl Sci. 2009. PMID: 20443898 Free PMC article. No abstract available.
-
Alzheimer's disease biomarkers: their value in diagnosis and clinical trials.Front Biosci. 2002 Apr 1;7:d986-8. doi: 10.2741/A824. Front Biosci. 2002. PMID: 11897567 Review.
-
Alzheimer's disease drug development: old problems require new priorities.CNS Neurol Disord Drug Targets. 2008 Dec;7(6):499-511. doi: 10.2174/187152708787122950. CNS Neurol Disord Drug Targets. 2008. PMID: 19128207 Free PMC article. Review.
Cited by
-
Molecular interactions of Alzheimer's biomarker FDDNP with Aβ peptide.Biophys J. 2012 Dec 5;103(11):2341-51. doi: 10.1016/j.bpj.2012.10.003. Biophys J. 2012. PMID: 23283233 Free PMC article.
-
HENA, heterogeneous network-based data set for Alzheimer's disease.Sci Data. 2019 Aug 14;6(1):151. doi: 10.1038/s41597-019-0152-0. Sci Data. 2019. PMID: 31413325 Free PMC article.
-
Two-Photon Fluorescent Probes for Amyloid-β Plaques Imaging In Vivo.Molecules. 2023 Aug 22;28(17):6184. doi: 10.3390/molecules28176184. Molecules. 2023. PMID: 37687013 Free PMC article. Review.
-
Searching for biomarkers in neurodegeneration.Nat Med. 2010 Dec;16(12):1371-2. doi: 10.1038/nm1210-1371b. Nat Med. 2010. PMID: 21135840 No abstract available.
-
Learning from genetic forms of neurodegeneration.Nat Med. 2010 Dec;16(12):1371. doi: 10.1038/nm1210-1371a. Nat Med. 2010. PMID: 21135841 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
